4575.T
Price:
$790
Market Cap:
$15.57B
CanBas Co., Ltd., a clinical stage biopharmaceutical company, develops therapeutics for cancer patients. It develops CBP501, a calmodulin-modulating peptide to treat various cancer; and CBS9106, a reversible exportin-1inhibitor that is in Phase I clinical trial for the treatment of solid tumors. The company has a collaboration alliance with Stemline Therapeutics, Inc. CanBas Co., Ltd. was incorporated in 2000 and is based in Numazu, Japan.
Industry
Biotechnology
IPO Date
2009-09-17
Stock Exchange
JPX
Ticker
4575.T
According to CanBas Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -12.92. This represents a change of -26.67% compared to the average of -17.62 of the last 4 quarters.
The mean historical PE Ratio of CanBas Co., Ltd. over the last ten years is -10.15. The current -12.92 PE Ratio has changed 12.63% with respect to the historical average. Over the past ten years (40 quarters), 4575.T's PE Ratio was at its highest in in the March 2017 quarter at 0. The PE Ratio was at its lowest in in the March 2023 quarter at -40.13.
Average
-10.15
Median
-8.80
Minimum
-19.56
Maximum
-5.73
Discovering the peaks and valleys of CanBas Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 124.62%
Maximum Annual PE Ratio = -5.73
Minimum Annual Increase = -48.07%
Minimum Annual PE Ratio = -19.56
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -19.56 | 124.62% |
| 2024 | -8.71 | -41.21% |
| 2023 | -14.81 | 101.59% |
| 2022 | -7.35 | 28.31% |
| 2021 | -5.73 | -35.53% |
| 2020 | -8.88 | -17.03% |
| 2019 | -10.71 | 47.06% |
| 2018 | -7.28 | -26.34% |
| 2017 | -9.88 | 15.49% |
| 2016 | -8.56 | -48.07% |
The current PE Ratio of CanBas Co., Ltd. (4575.T) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-14.36
5-year avg
-11.23
10-year avg
-10.15
CanBas Co., Ltd.’s PE Ratio is less than StemRIM (-8.18), less than Oncolys BioPharma Inc. (-10.22), less than CellSeed Inc. (-9.03), greater than ReproCELL Incorporated (-117.95), greater than RaQualia Pharma Inc. (-49.21), greater than Medical Data Vision Co., Ltd. (-25.09), greater than Japan Tissue Engineering Co., Ltd. (-71.06), less than NANO MRNA Co.,Ltd. (-11.87), less than Sunwels Co.,Ltd. (-5.60), less than MediciNova, Inc. (-6.48),
| Company | PE Ratio | Market cap |
|---|---|---|
| -8.18 | $15.78B | |
| -10.22 | $22.93B | |
| -9.03 | $9.36B | |
| -117.95 | $14.87B | |
| -49.21 | $27.61B | |
| -25.09 | $17.94B | |
| -71.06 | $20.39B | |
| -11.87 | $10.48B | |
| -5.60 | $12.16B | |
| -6.48 | $11.53B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CanBas Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CanBas Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CanBas Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for CanBas Co., Ltd. (4575.T)?
What is the highest PE Ratio for CanBas Co., Ltd. (4575.T)?
What is the 3-year average PE Ratio for CanBas Co., Ltd. (4575.T)?
What is the 5-year average PE Ratio for CanBas Co., Ltd. (4575.T)?
How does the current PE Ratio for CanBas Co., Ltd. (4575.T) compare to its historical average?